China Resources Medical Holdings Company Limited (1PH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, China Resources Medical Holdings Company Limited (1PH) has a cash flow conversion efficiency ratio of 0.038x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€270.22 Million ≈ $315.91 Million USD) by net assets (€7.18 Billion ≈ $8.39 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See China Resources Medical Holdings Company defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
China Resources Medical Holdings Company Limited - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how China Resources Medical Holdings Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
China Resources Medical Holdings Company Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of China Resources Medical Holdings Company Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Altshuler Shaham Financial LTD
TA:ALTF
|
0.052x |
|
i3 Verticals Inc
NASDAQ:IIIV
|
0.023x |
|
Citizens & Northern Corp
NASDAQ:CZNC
|
0.026x |
|
Nanjing Res In of Surveying Mapping
SHE:300826
|
0.002x |
|
Jiangsu Newamstar Packaging Machinery Co Ltd
SHE:300509
|
0.212x |
|
Centuria Office REIT
AU:COF
|
0.021x |
|
PT Temas Tbk
JK:TMAS
|
0.079x |
|
BHG Group AB (publ)
ST:BHG
|
0.003x |
Annual Cash Flow Conversion Efficiency for China Resources Medical Holdings Company Limited (2016–2024)
The table below shows the annual cash flow conversion efficiency of China Resources Medical Holdings Company Limited from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see China Resources Medical Holdings Company market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €7.50 Billion ≈ $8.77 Billion |
€1.27 Billion ≈ $1.49 Billion |
0.169x | -0.59% |
| 2023-12-31 | €7.01 Billion ≈ $8.20 Billion |
€1.20 Billion ≈ $1.40 Billion |
0.170x | +90.33% |
| 2022-12-31 | €7.00 Billion ≈ $8.18 Billion |
€626.58 Million ≈ $732.54 Million |
0.090x | -13.71% |
| 2021-12-31 | €6.85 Billion ≈ $8.00 Billion |
€710.43 Million ≈ $830.57 Million |
0.104x | +2.21% |
| 2020-12-31 | €6.34 Billion ≈ $7.41 Billion |
€643.69 Million ≈ $752.54 Million |
0.102x | +70.29% |
| 2019-12-31 | €6.14 Billion ≈ $7.18 Billion |
€366.05 Million ≈ $427.95 Million |
0.060x | +1.87% |
| 2018-12-31 | €5.71 Billion ≈ $6.68 Billion |
€334.15 Million ≈ $390.65 Million |
0.059x | -28.67% |
| 2017-12-31 | €5.60 Billion ≈ $6.55 Billion |
€459.54 Million ≈ $537.25 Million |
0.082x | +96.40% |
| 2016-12-31 | €5.36 Billion ≈ $6.26 Billion |
€223.79 Million ≈ $261.63 Million |
0.042x | -- |
About China Resources Medical Holdings Company Limited
China Resources Medical Holdings Company Limited, an investment holding company, provides general healthcare, hospital management, and other hospital-related services in the People's Republic of China. It operates through two segments Hospital and Other Business. The Hospital segment offers out-patient and in-patient business corresponding to self-owned hospitals. The Other Business segment offer… Read more